Live Virtual Presentation Clinical Oncology Society of Australia Annual Scientific Meeting 2020

Management of cardiotoxicity: What do the guidelines tell us? (#59)

Liza Thomas 1
  1. Westmead Hospital/ University of Sydney and UNSW, Westmead, NSW, Australia

 As cancer survivorship is increasing, cardiotoxicity is increasingly being recognised. Several cancer therapies can have a deleterious effect on cardiac function, some of which are reversible, some dose related and some irreversible. While this is a developing area, cardioprotective therapies have shown benefit especially if commenced early. Longer term benefits of cardioprotective therapy need to be determined.